Cigarette smoking and liver diseases

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

Forouzanfar, M. H., Afshin, A., Alexander, L. T., Anderson, H. R., Bhutta, Z. A., Biryukov, S., Brauer, M., Burnett, R., Cercy, K., Charlson, F. J., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31679-8 · Cited by 7,698

Liver fibrosis

Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958

NAFLD: A multisystem disease

Byrne, C. D., & Targher, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.012 · Cited by 3,144

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

Angulo, P., Kleiner, D. E., Dam-Larsen, S., Adams, L. A., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Keach, J. C., Lafferty, H. D., Stahler, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.043 · Cited by 2,987

Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies

D'Amico, G., Garcia-Tsao, G., & Pagliaro, L. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.10.013 · Cited by 2,687

Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015

Reitsma, M. B., Fullman, N., Ng, M., Salama, J. S., Abajobir, A., Abate, K. H., Abbafati, C., Abera, S. F., Abraham, B., Abyu, G. Y., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30819-x · Cited by 2,028

TLR4 enhances TGF-β signaling and hepatic fibrosis

Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942

Association between smoking, smoking cessation and serum α-klotho levels among American adults: National Health and Nutrition Examination Survey

Liu, T., Song, M., Li, J., Zhao, Y., & Zhong, W. (2024) · PLoS ONE · doi:10.1371/journal.pone.0300562 · Cited by 3

Association between blood chromium and hepatic steatosis assessed by liver ultrasound transient elastography: National Health and Nutrition Examination Survey 2017–2020

Xiang, Y., Zhou, R., Wang, Z., Xue, Y., Cao, Y., Shen, L., Zhu, Z., Xu, P., Zhou, G., & Shang, W. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1307519 · Cited by 3

It's not all about the virus—On the importance of modifiable lifestyle factors in the development of hepatocellular carcinoma in chronic hepatitis B

Jachs, M., & Tillmann, H. L. (2022) · Hepatology · doi:10.1002/hep.32798 · Cited by 3

Prevention of Alcohol-Associated Liver Disease

Burton, R., Leggio, L., Louvet, A., Sheron, N., & Singal, A. K. (2025) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003427 · Cited by 2

Long-term risk of irritable bowel syndrome associated with MASLD, MASLD type and different cardiometabolic risk factors: a large-scale prospective cohort study

Zhou, Y., Yang, Z., Liu, S., Xie, S.-A., Zhang, Q., Zhang, S., Zhu, S., & Wu, S. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-04165-7 · Cited by 3

Cardiovascular Disease Meets Cancer: Exploring the Epidemiology in China and Homotherapy Targeting Intersectional Mechanisms

Xiang, S., Shan, Y., Shi-hong, X., Wang, J., Luo, M., Zhou, J., & Chen, Q. (2025) · Advanced Science · doi:10.1002/advs.202501820 · Cited by 2

Mass spectrometry-based absolute quantitative proteomics of drug-metabolizing enzymes in human liver

McCalla, Z., & Wang, X. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108929 · Cited by 2

Early-life exposure to tobacco smoke and chronic liver disease incidence in adulthood

Xu, X., Li, J., Fu, Y., Li, J., Shen, W., Tan, X. W., Wu, J., Wang, N., Lu, Y., & Wang, B. (2025) · Annals of Hepatology · doi:10.1016/j.aohep.2025.102168 · Cited by 2

A cigarette compound-induced tumor microenvironment promotes sorafenib resistance in hepatocellular carcinoma via the 14-3-3η-modified tumor-associated proteome

Jin, M. L., Du, X., Dong, N., Feng, Z., Sun, Y., Song, S., Zhang, H., Li, M., Duan, S., Lü, M., et al. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003851 · Cited by 2

Educational disparities in alcohol‐related liver disease mortality in the 21st century: Beyond deaths of despair?

Grucza, R. A., Hwang, J. J., Scherrer, J. F., Bello, J. K., Gebauer, S. C., Huang, R., Salas, J., & Xu, K. Y. (2025) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.70194 · Cited by 2

The impact of genetic and environmental risk factors on adverse liver outcomes

Zhang, X., Zhao, L., Campbell, P. T., Chen, Y., Fang, A., Liu, Z., Li, X., Yang, W., Fan, J., Petrick, J. L., et al. (2025) · International Journal of Cancer · doi:10.1002/ijc.70259 · Cited by 2

The Alpha‐1 Pi * MZ Genotype Is an Independent Risk Factor for Hepatocellular Carcinoma Development in Patients With ACLD

Balcar, L., Semmler, G., Scheiner, B., Paternostro, R., Simbrunner, B., Haunold, T. J., Jachs, M., Hartl, L., Hofer, B., Dominik, N., et al. (2026) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.70530 · Cited by 2

Growth Differentiation Factor 15 (GDF-15) as a modulator of hepatic steatosis and fibrosis: insights from a 6-year retrospective cohort study

Dietzel, N. A., Schmidt, M., Wiegand, J., Berg, T., Biemann, R., Baber, R., Kluge, M., Wirkner, K., & Wittekind, D. A. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1733339 · Cited by 2

The role of primary care in response to the global liver disease syndemic: a Lancet Gastroenterology & Hepatology Commission

Jarvis, H., Brennan, P., Casanovas, T., Casler, K., Desai, M., Evans, P. H., Dillon, J. F., Grattagliano, I., Hallsworth, K., Hebditch, V., et al. (2026) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(26)00015-4 · Cited by 3

Estimating the Direct Medical Costs of Smoking-Attributable Non-communicable Diseases in Northeastern Iran From 2015 to 2023

Abbasi, A., Tajik, A., Sharifi, F., Moghri, J., Momken, M., Khalse, Z., & Varmaghani, M. (2025) · Tobacco Use Insights · doi:10.1177/1179173x251337114 · Cited by 2

A new integrative learning framework for integrating multiple secondary outcomes into primary outcome analysis: a case study on liver health

Deng, D., Han, P., Chen, S., Wang, M., & Chen, C. (2025) · Journal of the Royal Statistical Society Series B (Statistical Methodology) · doi:10.1093/jrsssb/qkaf081 · Cited by 2

Liver stiffness and associated risk factors among people with a history of injecting drugs: a prospective cohort study

Druckrey-Fiskaaen, K. T., Vold, J. H., Madebo, T., Midgard, H., Dalgård, O., Leiva, R. A., Fadnes, L. T., for the INTRO-HCV Study Group, Buljovcic, V. B., Daltveit, J. T., et al. (2024) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-024-00603-z · Cited by 2

Incidence risk of hepatobiliary malignant neoplasms in the cohort of workers chronically exposed to ionizing radiation

Zhuntova, G. V., Bannikova, M. V., & Azizova, T. V. (2024) · Scientific Reports · doi:10.1038/s41598-024-63503-z · Cited by 1

Post-transplant complications in alcohol- and metabolic-associated steatotic liver disease

Jadaun, S. S., & Saigal, S. (2024) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2024.62 · Cited by 1

Cluster analysis of diet and lifestyle factors associated with metabolic dysfunction-associated steatotic liver disease: findings from Korean Genome and Epidemiology Study

Lee, J.-H., Ryu, H. E., Han, T., Park, B., Heo, S., & Kwon, Y. (2025) · Endocrine · doi:10.1007/s12020-025-04200-3 · Cited by 1

Mendelian randomization analysis of smoking, BMI, and nonalcoholic fatty liver disease in European descent populations

Ma, L., Jiang, H., & Qu, N. (2025) · Medicine · doi:10.1097/md.0000000000042308 · Cited by 1

Liver Disease and Nutrition: An Overview

Sahu, S., Bhavanam, S., & Younas, S. (2025) · Springer eBooks · doi:10.1007/978-3-031-32047-7_185-1 · Cited by 1

Non-invasive detection of fibrosis in non-alcoholic fatty liver disease by serum microfibrillar-associated protein 4 and its correlation with FIB-4 and transient elastography

Eltony, H. A. R., Kasem, G., Elsharaby, R. M., Badawi, R., & Helal, E. M. (2025) · Egyptian Liver Journal · doi:10.1186/s43066-025-00439-7 · Cited by 1

Ubiquitous Environmental Exposures and Risk of Hepatocellular Carcinoma: A Narrative Review

Abate, H. M., Bujnowski, D., Jowell, A. H., Moylan, C. A., Hoyo, C., & Wegermann, K. (2025) · Digestive Diseases and Sciences · doi:10.1007/s10620-025-09212-7 · Cited by 2

Comparison of Risk Factors, Their Interaction Patterns, and Scoring Systems for Liver Cancer Between Patients With and Those Without Diabetes: Retrospective Cohort Study Using Electronic Health Records and Tree-Structured Algorithms

Yau, S. T. Y., Hung, C. T., Leung, E. Y. M., Lee, A., & Yeoh, E. (2025) · JMIR Medical Informatics · doi:10.2196/72239 · Cited by 1

E-cigarette vaping is associated with pro-fibrotic gene expression in kidney and liver tissues

Gu, W., Chang, H. H., Saini, P., Gaboyan, S., Olay, J., Masso-Silva, J. A., Shin, J., Advani, I. N., Du, A., Brand, C. S., et al. (2026) · Journal of Molecular Medicine · doi:10.1007/s00109-026-02699-1 · Cited by 1

Association of circadian-metabolic syndrome with incident chronic liver disease in middle-aged and elderly Chinese adults: a prospective cohort study on mediation by cardiovascular disease

Yang, X., Ma, J., Xu, L., & Li, H. (2025) · European journal of medical research · doi:10.1186/s40001-025-03329-1 · Cited by 1

Research advances in self-assembled peptide delivery systems for fibrosis treatment

Zhang, Y., Su, D., & Wang, Y. (2025) · Precision medicine and engineering. · doi:10.1016/j.preme.2025.100043 · Cited by 1

Cigarette smoke exposure worsens the severity of alcoholic liver disease by increasing CYP pathway signaling in mice

Jeong, H., Kim, J.-W., Yang, D., Kim, M.-S., Lee, K., & Kim, B. (2026) · Toxicological Research · doi:10.1007/s43188-025-00336-6 · Cited by 1

Serum polychlorinated biphenyls and risk of metabolic dysfunction-associated steatotic liver disease: Cross-sectional and prospective analyses from the Dongfeng-Tongji cohort

You, Y., Guo, Y., Guan, X., Zhong, G., Yin, Y., Yin, Z., Wen, Y., Li, W., Zhao, H., Chen, S., et al. (2026) · Environmental Pollution · doi:10.1016/j.envpol.2026.127985 · Cited by 1

Lifespan approaches for the prevention and management of steatotic liver disease

Zelber‐Sagi, S., Ivancovsky-Wajcman, D., Kugelmas, C., Weinstein, A. A., Wong, V. W., Castéra, L., Moore, J. B., Mouzaki, M., Hallsworth, K., Paik, J. M., et al. (2026) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-026-01198-5 · Cited by 1

Impact of Traditional Cigarette Smoking on Liver Structure and Function

Jukić, I., Matulić, I., Bečić, T., Radić, M., Radić, J., Fabijanić, D., & Vuković, J. (2026) · Livers · doi:10.3390/livers6030034 · Cited by 1

Smoking and Risk of Hepatic Steatosis Within the MASLD Spectrum in Korean Young Adults

Jee, Y., Lee, S. J., Chun, H. S., & Shin, H. (2026) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.70550 · Cited by 1

Effect of Implementing Nursing Protocol on clinical Outcomes of Acute Non- variceal Upper Gastrointestinal Bleeding Patients

Mohamed, S., Abouzied, W., Soliman, E., & Mohamed, R. D. (2023) · Tanta Scientific Nursing Journal · doi:10.21608/tsnj.2023.285674 · Cited by 1

A novel nomogram based on GD for predicting prognosis in hepatocellular carcinoma

Liu, Y., Cui, K., Zhao, H., & Ma, W. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1174788 · Cited by 1

Effect of Honey and Aqueous Garlic Extracts against Short-Term Exposure of Cigarette Tobacco Smoking in Mice: Histopathological and Biochemical Investigations

Shraideh, Z. A., Badran, D. H., & Alzbeede, A. A. (2024) · Journal of Toxicology · doi:10.1155/2024/5539447 · Cited by 2

Influence of major non-communicable chronic disease diagnoses on Chinese adult males' smoking behavior: is there a moderating role for the home environment?

Hu, Y., Chen, Q., Zheng, H., & Liang, Y. (2024) · Journal of Men s Health · doi:10.22514/jomh.2024.037 · Cited by 1

Internal Malignancy Risk After Carbon Monoxide Poisoning: A Nationwide Population-Based Cohort Study

Ahn, G. J., Lee, S., Lee, S. J., & Sung, Y. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14030937 · Cited by 1

Ascertaining the association between smoking behaviors and viral hepatitis risk: A Mendelian randomization approach

Lin, B., Ma, H., Yan, L., LIN, T. ‐., Han, X., Lin, M., & Gao, H. (2025) · Tobacco Induced Diseases · doi:10.18332/tid/204511 · Cited by 1

Molecular mechanisms underlying roles of long non-coding RNA small nucleolar RNA host gene 16 in digestive system cancers

Yang, T.-F., Li, X.-R., & Kong, M.-W. (2024) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v16.i11.4300 · Cited by 1

SMOKING PERTURBED LIVER MACHINERY RELEVANT TO MITOCHONDRIAL FUNCTIONS

Mohammad, R. H., & Kattan, M. A. A. (2023) · Military Medical Science Letters · doi:10.31482/mmsl.2022.052

Tea consumption and risk of digestive tract tumors: a two-sample Mendelian randomization studyPreprint

Wang, S., Xing, Y., Jin, Z., & Wang, R. (2023) · Research Square · doi:10.21203/rs.3.rs-2616316/v1

The effect of Callina papaya (Carica papaya L. var. Callina) leaves extract on histopathology of kidney and liver in cigarette smoke-exposed rats (Rattus norvegicus Berkenhout, 1769)

Setiawan, H., Maimunah, S., Husna, H., Angganawati, R., Putri, S. A., & Cahyani, C. (2023) · Biogenesis Jurnal Ilmiah Biologi · doi:10.24252/bio.v11i1.36341

Impact of low alcohol consumption in the natural history of cirrhosis

Aguado, D. M., & Vilar‐Gómez, E. (2024) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn-23-615

Comparison of non-invasive scores predictive of development of metabolic dysfunction associated liver disease in patients of type 2 diabetes mellitus and evaluation of additive effect of smoking in these patients

Singla, H. (2024) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20240665

Hepatitis B and C Viruses: Prevalence and co-factors among patients with liver cirrhosis

Rahatullah, H. S. (2024) · Multidisciplinary Science Journal · doi:10.31893/multiscience.2024142

The smoker's paradox in transjugular intrahepatic portosystemic shunt procedure: A national inpatient sample analysis from 2015 to 2020

Li, R., & Sarin, S. N. (2024) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2024.102323

Causal effect between immunocytes, plasma metabolites, and hepatocellular carcinoma: a bidirectional two-sample Mendelian randomization study and mediation analysisPreprint

Tang, X., Xue, J., Zhang, J., & Zhou, J. (2024) · Research Square · doi:10.21203/rs.3.rs-4740840/v1

Reply to: “Is liver fibrosis more advanced in MetALD than in MASLD?”

Oh, J. H., & Jun, D. W. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.09.024

Coagulopathy And D-dimer Level Changes In Chronic Liver Disease And CirrhosisPreprint

Hezam, A. A., & Alqubati, K. (2024) · Research Square · doi:10.21203/rs.3.rs-5412218/v1

Alcohol Plus Additional Risk Factors: Rodent Model of Liver Injury

Wu, Q., Yang, D., Liu, C., & Xu, T. (2024) · Seminars in Liver Disease · doi:10.1055/a-2490-4278 · Cited by 1

Is There an Association Between Cigarette Smoking and Advanced Liver Fibrosis in Smokers with HIV, Heavy Drinking and High Prevalence of HCV?

Fuster, D., So‐Armah, K., Cheng, D. M., Blokhina, E. A., Patts, G. J., Lioznov, D. A., Gnatienko, N., Long, M. T., Freiberg, M. S., Tindle, H. A., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14041169

Risk factors, their interaction patterns, and scoring systems for liver cancer: comparison between patients with and without diabetes using tree-structured algorithms (Preprint)Preprint

Yau, S. T. Y., Hung, C. T., Leung, E. Y. M., Lee, A., & Yeoh, E. (2025) · doi:10.2196/preprints.72239

Metabolic dysfunction associated steatotic liver disease in lean patients. Diagnostic and treatment challenges

Zabotina, E. E., Khabarova, Y. A., & Stukova, N. Y. (2025) · Experimental and Clinical Gastroenterology · doi:10.31146/1682-8658-ecg-229-9-96-109

Enhancing Vision-Based Cigarette Smoke Detection in Smart Vehicles by Transfer Learning

Bappi, M. I., Jin, H., & Kim, K. (2025) · Journal of Digital Contents Society · doi:10.9728/dcs.2025.26.4.1041

Assessment of Toxoplasma immunoglobulins, α-fetoprotein, and dopamine sera levels: insights into heroin addicts’ characteristics

Shaheen, S. H., Saftawy, E. A. E., Aboulhoda, B. E., Abdulwehab, M. M., Ibrahim, A. F., Zein, M. M., Farag, M. F., Salama, N. M., Elwi, H. M., Elkholy, N. S., et al. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-07055-0

Population-Scale Liver Volume Nomograms: Data-Driven Insights from High-Throughput Imaging and Clinical Data IntegrationPreprint

Wang, Y., Yamamoto, M., Martin, M., Macdonald, J. A., Kadi, D., Lafata, K. J., & Bashir, M. R. (2025) · medRxiv · doi:10.1101/2025.07.17.25331751

Lifestyle Measures and the Risk of Metabolic Dysfunction-Associated Steatotic Liver Disease: A Cross-Sectional Study

Correia-Chaves, J., Borges‐Canha, M., Leite, A. R., Gomes, L., Lourenço, I. M., von Hafe, M., Vale, C., Liberal, R., Fragão-Marques, M., Pimentel‐Nunes, P., et al. (2025) · Endocrinology Insights · doi:10.1159/000548515

Prevalence and Trends in Active Smoking Among Adults Living with HCV in the U.S. over the Last Decade: A Population-Level Analysis

Alabbas, M., Shi, J., Guo, Y., Wu, H., Oshobu, I. E., Castano, M., Mahmoud, W., Sengupta, S., & Sims, O. T. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14186671

Cadmium Exposure and Hepato-renal Injury in Response to Cigarette Smoking in Apparently Healthy Active Smokers in Buea-CameroonPreprint

Ramin, J. N. N., Kouam, A. F., Menkem, E. Z., Seukep, A. J., Fepa, A. G. K., Ella, F. A., Djamen, P. D. C., Njayou, F. N., Moundipa, P. F., & Asongalem, E. A. (2025) · medRxiv · doi:10.1101/2025.09.21.25336294

Foie métabolique

Saviano, A., & Serfaty, L. (2025) · EMC - Hépatologie · doi:10.1016/s1155-1976(25)46793-x

Hepatology clinician readiness to provide addiction treatment in hepatology clinics: A mixed-methods formative evaluation

Haque, L., Choi, H. Y., Justen, M., Deng, Y., Edelman, E. J., & Fiellin, D. A. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000818

Dietary and Lifestyle Risk Factors in Primary Sclerosing Cholangitis: In Search of Mechanistic Explanations and Health Improvement

Mammadov, R. A., Roest, H. P., van der Laan, L. J. W., & Peppelenbosch, M. P. (2025) · Journal of Nutrition · doi:10.1016/j.tjnut.2025.10.041 · Cited by 1

A study of different pre-treatment methods for cigarettes and their aroma differences

Li, D., Gu, Y., Zhang, C., Fei, T., Ma, L., Wu, R., Tao, L., Tian, Z., & Feng, T. (2025) · Open Chemistry · doi:10.1515/chem-2025-0209

Medium distances to specialized care models at tertiary hospitals and socioeconomic neighborhood-related factors do not influence the quality of care for patients with liver cirrhosis

Michl, S. H., Meindl‐Beinker, N. M., Moghadam, A. D., Antoni, C., Klindt-Morgan, C., Kusnik, A. T., Weiß, C., Ebert, M., Weiss, K. H., & Teufel, A. (2025) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000003094

Risk assessment of daikenchuto-induced hepatobiliary injury in colon cancer patients post-colectomy: a retrospective cohort study

Watanabe, S., Wada, Y., Nagata, J., Asakawa, T., Hirata, K., & Fujino, Y. (2025) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-025-05186-1

Additional file 1 of Liver stiffness and associated risk factors among people with a history of injecting drugs: a prospective cohort study

Druckrey-Fiskaaen, K. T., Vold, J. H., Madebo, T., Midgard, H., Dalgård, O., Leiva, R. A., & Fadnes, L. T. (2024) · Figshare · doi:10.6084/m9.figshare.25485835

Additional file 1 of Development of a prediction model for predicting the prevalence of nonalcoholic fatty liver disease in Chinese nurses: the first-year follow data of a web-based ambispective cohort study

Che, Y., Rongsong, T., Zhang, H., Yang, M., Geng, R., Zhuo, L., Wang, P., Hu, X., Zhou, Y., Wang, P., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26680921

Coagulopathy and D-Dimer Level Changes Among Yemeni Patients with Chronic Liver Disease and Cirrhosis

Hezam, A. A., & AI-Qubati, K. (2025) · doi:10.61440/jge.2025.v3.34

Polyunsaturated fatty acids as a potential preventive and therapeutic intervention for metabolic dysfunction–associated steatotic liver disease and its progression to hepatocellular carcinoma

Kouti, T., Christodoulou, P., Christodoulides, S., Protopapa, F., Michaeloudes, C., & Farazi, P. A. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1767917

Management of Metabolic Dysfunction-Associated Steatotic Liver Disease with Lifestyle Modification

Ivancovsky-Wajcman, D., Pekas, E. J., de Avila, L., Gerber, L. H., & Zelber‐Sagi, S. (2026) · Clinics in Liver Disease · doi:10.1016/j.cld.2026.01.002

Prevalence and Clinical Impact of Smoking and Obesity Among Thalassemia Patients in Egypt: A Single-Center StudyPreprint

Juma, L. F., Alwadi, K., Habib, H., Laith, J. A., & Jamal, E. (2026) · Research Square · doi:10.21203/rs.3.rs-9128384/v1

Low awareness of viral causes of Cancer among United States adults by smoking status: findings from health information national trends survey (2024)

Lin, W., Wang, S., & Ge, L. (2026) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2026.103466

Trends and risk factors associated with severity and mortality related to hepatitis A in French hospitals: a national population-based study, 2013 to 2024Preprint

Roque‐Afonso, A., Mouliade, C., Parlati, L., Goutté, N., Figoni, J., Bouam, S., Sogni, P., & Mallet, V. O. (2026) · medRxiv · doi:10.64898/2026.04.30.26351819

Cadmium exposure as a contributing factor to hepato-renal injury in apparently healthy active cigarette smokers in buea-cameroon

Ramin, J. N. N., Kouam, A. F., Menkem, E. Z., Seukep, A. J., Fepa, A. G. K., Ella, F. A., Djamen, P. D. C., Njayou, F. N., Moundipa, P. F., & Asongalem, E. A. (2026) · PLoS ONE · doi:10.1371/journal.pone.0333775

The Use of Lycium barbarum Polysaccharides to Control Liver Disease: A Review

Wang, L.-J., Sun, J.-G., Chen, S., Zhang, P., Sun, Y.-L., Zheng, Y., & Feng, J.-C. (2026) · World Journal of Traditional Chinese Medicine · doi:10.4103/wjtcm.wjtcm_68_26

Smoking-induced liver injury and related diseases: Molecular mechanisms, pathogenic amplification, and clinical implications

Wen, X., Xue, T.-Y., Yang, Y.-H., Mai, Y.-P., Wang, Q.-S., Wang, X.-X., Chen, D.-B., Chen, H., & Wang, Z.-X. (2026) · World Journal of Hepatology · doi:10.4254/wjh.119664

Apple Seed Extract Post-Treatment Alters Selected IGF-Related and Extracellular Matrix-Associated Markers Following Tobacco Leaf Extract-Induced Histological Liver Injury

Oh, M. J., Park, Y.-S., Mo, J.-Y., Kang, E. K., Kang, C. W., & Kim, S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27135851

The spectrum of steatotic liver disease in the USA

Scherübl, H. (2026) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(26)00129-9

MASLD and Pancreatic Diseases: From Shared Mechanisms to Clinical Implications and Future Directions

Rivera‐Esteban, J., Agudo, B., Patrizi, B., Manzur, A., de la Iglesia, D., Valverde-Salazar, V., Ferris, N. G., Esteban, C., Santos, E., Pons, F., et al. (2026) · Nutrients · doi:10.3390/nu18152480

Heatwave exposure and gastrointestinal and liver diseases: complementary evidence from a population-based study and animal experiments

Du, Y., Wu, M., Wu, H., Wu, Y., Fang, C., Li, L., Zhang, H.-T., & Wang, Y. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1883010

Alcohol, cardiometabolic risk factors, and cirrhosis: Ten-year risk estimates from a population-based Danish cohort

Rønn, J. H., Jepsen, P., Mellinger, J. L., Innes, H. A., Eliasen, M., Christensen, A. I., Madsen, L. G., & Askgaard, G. (2026) · Journal of Hepatology · doi:10.1016/j.jhep.2026.08.017

Sex-specific biological aging clocks across organs and omics

Song, Z., Feng, D., Rahman, N. A., Duggan, M. R., Tian, Q., Zeng, J., Zhou, X., Zou, C., Rafii, M. S., Shen, L., et al. (2026) · Nature Medicine · doi:10.1038/s41591-026-04662-6 · Cited by 1

Prevalence of steatotic liver disease phenotypes and liver fibrosis in people with HIV in Egypt

Cordie, A., Mohamed, R., Sebastiani, G., Garhy, N. E., Sehemy, L. A., Saweres, A., Nagy, M. S., Awad, R. A., Atef, R., Al-sharif, A. M., et al. (2026) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1093/trstmh/trag110

AGA Clinical Practice Update on the Evaluation and Management of Metabolic Dysfunction– and Alcohol-Associated Liver Disease: Expert Review

Arab, J. P., Malhi, H., Winder, G. S., & Fontana, R. J. (2026) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2026.07.027

Allostatic load, unhealthy behaviors, and mortality risk among participants with and without metabolic dysfunction–associated steatotic liver disease

Hong, D., Xi, B., Lv, Z., Li, N., He, X., Zhu, X., Zhang, J., Wang, C., Cai, Z., Wu, H., et al. (2026) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000003290

Trends and risk factors associated with hepatitis A severity and mortality in French hospitals: a national population-based study, 2013 to 2024

Roque‐Afonso, A., Mouliade, C., Parlati, L., Goutté, N., Figoni, J., Bouam, S., Sogni, P., & Mallet, V. O. (2026) · Eurosurveillance · doi:10.2807/1560-7917.es.2026.31.39.2500858

ACG Clinical Guideline: Preventive Care for Patients With Cirrhosis

Tapper, E. B., Kardashian, A. A., Debes, J., Gripshover, J., Moon, A. M., Kim, J. J., & Lai, J. C. (2026) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000004186

Crosstalk along the gut–liver axis in liver disease: Clinical and mechanistic aspects

Nakamoto, N., Okada, H., Bäckhed, F., Schnabl, B., & Hov, J. R. (2026) · Journal of Hepatology · doi:10.1016/j.jhep.2026.10.019

Knowledge Mapping of Ultrasound-guided Thermal Ablation Combined with Immunotherapy for Hepatocellular Carcinoma: A Systematic Bibliometric Analysis

Sui, Y., Meng, W., Li, R., Li, L., & Xu, Z. (2026) · Advanced ultrasound in diagnosis and therapy · doi:10.26599/audt.2026.250115

Integrating multi-omics and systems thinking—The future of liver cancer research

Basera, A., Mpala, S., Fadebi, O. O., Marutha, T., Marima, R., Lolas, G., & Dlamini, Z. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45925-2.00010-x

Smoking and liver diseases: an updated review of pathogenesis, progression, and therapeutic implications

El-Azab, G., Elkhouly, E., Abouyoussef, R. A. M., & Nagdy, H. M. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-01922-6 · Cited by 12

Smoking and Liver Disease.

Rutledge, S. M., & Asgharpour, A. (2020) · PubMed Central · Cited by 72

Smoking-induced liver injury and related diseases: Molecular mechanisms, pathogenic amplification, and clinical implications

Wen, X., Xue, T.-Y., Yang, Y.-H., Mai, Y.-P., Wang, Q.-S., Wang, X.-X., Chen, D.-B., Chen, H., & Wang, Z.-X. (2026) · World Journal of Hepatology · doi:10.4254/wjh.119664

Clearing the Smoke in Chronic Liver Diseases

Zein, C. O. (2010) · Hepatology · doi:10.1002/hep.23694 · Cited by 30

Time to ban smoking in patients with chronic liver diseases

Bataller, R. A. (2006) · Hepatology · doi:10.1002/hep.21484 · Cited by 40